LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,187
تعداد مقالات10,824
تعداد مشاهده مقاله72,833,581
تعداد دریافت فایل اصل مقاله12,911,444
Motahari, Paria, Fathollahzadeh, Davood, Alipour, Amir. (1402). Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis. سامانه مدیریت نشریات علمی, 24(3), 277-284. doi: 10.30476/dentjods.2022.94772.1809
Paria Motahari; Davood Fathollahzadeh; Amir Alipour. "Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis". سامانه مدیریت نشریات علمی, 24, 3, 1402, 277-284. doi: 10.30476/dentjods.2022.94772.1809
Motahari, Paria, Fathollahzadeh, Davood, Alipour, Amir. (1402). 'Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis', سامانه مدیریت نشریات علمی, 24(3), pp. 277-284. doi: 10.30476/dentjods.2022.94772.1809
Motahari, Paria, Fathollahzadeh, Davood, Alipour, Amir. Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis. سامانه مدیریت نشریات علمی, 1402; 24(3): 277-284. doi: 10.30476/dentjods.2022.94772.1809

Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis

Journal of Dentistry
مقاله 2، دوره 24، شماره 3 - شماره پیاپی 80، آذر 2023، صفحه 277-284    اصل مقاله (668.02 K)
نوع مقاله: Systematic Review
شناسه دیجیتال (DOI): 10.30476/dentjods.2022.94772.1809
نویسندگان
Paria Motahari* 1؛ Davood Fathollahzadeh2؛ Amir Alipour3
1Dept. of Oral Medicine, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
2Dept. of Oral Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
3Dental Student, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
چکیده
Recurrent aphthous stomatitis (RAS) has been identified as a common oral lesion with an unknown pathogenesis. Various studies have been conducted to show the important role of two factors named epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) in RAS, but certain results have not been achieved. The present meta-analysis was conducted to evaluate the salivary levels of EGF and VEGF in patients with RAS. For this purpose, the related articles in the Web of Science, PubMed, Embase, ProQuest and Scopus databases until January 2022 were searched and their abstracts were studied. Google scholar and scientific information database were also searched for articles in Persian. The searches were completed by the medical subject heading terms considering "recurrent aphthous stomatitis" and "saliva" in combination with "EGF" or "VEGF" keywords. All case control studies that evaluated the salivary levels of EGF and VEGF in patients with RAS were included in this study. To evaluate statistical heterogeneity between the studies, Cochrane Q and I2 tests were adopted. The extracted data then were used in the analysis process based on comprehensive meta-analysis software. Originally, 619 articles were considered, of which 7 articles were selected. According to this meta-analysis, salivary EGF and VEGF levels were significantly lower in the active and remission period of RAS than in healthy individuals (p Value< 0.05). In addition, salivary levels of these factors were significantly lower in the active stage of RAS than in the healing phase. This review study suggests that decreasing of salivary EGF and VEGF levels have significant role in the development of RAS.

تازه های تحقیق

Paria Motahari  Google Scholar

کلیدواژه‌ها
Epidermal growth factor؛ Vascular endothelial growth factors؛ Stomatitis, Aphthous
سایر فایل های مرتبط با مقاله
مراجع
  • Chattopadhyay A, Shetty KV. Recurrent aphthous stomatitis. Otolaryngol Clin North Am. 2011; 44: 79-88.
  • Kumar M, Ananthakrishnan V, Goturu J. Etiology and pathophysiology of recurrent aphthous stomatitis: a review. Int J Cur Res Rev. 2014; 6: 16.
  • Natah SS, Konttinen YT, Enattah NS. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg. 2004, 33: 221–234.
  • Preeti L, Magesh K, Rajkumar K, Karthik R. Recurrent aphthous stomatitis. J Oral Maxillofac Pathol. 2011; 15: 252-256.
  • Pourzare mehrbani S, Motahari P, Zaheri F. Evaluation of salivary folate, ferritin, and vitamin B12 in patients with recurrent aphthous ulcers. J Mash Dent Sch. 2020; 44: 209-215.
  • Motahari P. Evaluation of antioxidant-oxidant status of saliva in recurrent aphthous stomatitis: A systematic review. J Oral Health Oral Epidemiol. 2020; 9: 60-64.
  • Motahari P, Pournaghi-Azar F, Khodadadi P. Role of tumor necrosis factor-alpha in pathogenesis of recurrent aphthous stomatitis: A systematic review and meta-analysis. J Oral Health Oral Epidemiol. 2020; 9: 108-115.
  • Buño IJ, Huff JC, Weston WL, Cook DT, Brice SL. Elevated levels of interferon gamma, tumor necrosis factor α, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol. 1998; 134: 827–831.
  • Slebioda Z, Szponar E, Kowalska A. Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: literature review. Arch Immunol Ther Exp (Warsz). 2014; 62: 205-215.
  • Lewkowicz N, Lewkowicz P, Kurnatowska A, Banasik M, Glowacka E, Cedzyński M, et al. Innate immune system is implicated in recurrent aphthous ulcer pathogenesis. J Oral Pathol Med. 2003; 32: 475-481.
  • Noguchi S, Ohba Y, Oka T. Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am J Physiol. 1991; 260: 620-625.
  • Hardwicke J, Schmaljohann D, Boyce D, Thomas D. Epidermal growth factor therapy and wound healing-past, present and future perspectives. Surgeon. 2008; 6: 172-177.
  • Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res. 2009; 153: 347-358.
  • Pammer J, Weninger W, Mildner M, Burian M, Wojta J, Tschachler E. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol. 1998; 186: 186-191.
  • Brand HS, Veerman EC. Saliva and wound healing. Chin J Dent Res. 2013; 16: 7-12.
  • Arbiser JL, Johson D, Cohen C, Brown LF. High- level expresseion of vascular endothelial growth factor and its receptors in an aphthous ulcer. J Cutan Med Surg. 2003; 7: 225-228.
  • Wu-Wang CY, Patel M, Feng J, Milles M, Wang SL. Decreased levels of salivary prostaglandin E2 and epidermal growth factor in recurrent aphthous stomatitis. Arch Oral Biol. 1995; 40: 1093-1098.
  • Adişen E, Aral A, Aybay C, Gürer MA. Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis. Dermatol. 2008; 217: 235-240.
  • Agha-Hosseini F, Kaviani H, Bamdad K. An investigation on the levels of vascular endothelial growth factor (VEGF) in the unstimulated whole saliva of patients with recurrent aphthous stomatitis. J Dent Tehran U Med Sci. 2005; 2: 96-100.
  • Brozovic S, Vucicvic–Boras V, Mravak-Stipetik M, Jukic S, Kleinheiz J, Lukac J. Salivary levels of vascular endothelial growth factor (VEGF) in recurrent aphthous ulceration. J Oral Pathol Med. 2002; 31: 106-108.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6: e1000097.
  • Stern C, Jordan Z, McArthur. A Developing the review question and inclusion criteria. Am J Nurs. 2014; 114: 53–56.
  • Santos WMD, Secoli SR, Püschel VAA. The Joanna Briggs Institute approach for systematic reviews. Rev Lat Am Enfermagem. 2018; 26: e3074.
  • Rezaei F, Hosseini E, Rezaei F. Comparison of salivary epidermal growth factor in patients with recurrent aphthous stomatitis, smokers, and healthy individuals. J Family Med Prim Care. 2019; 8: 2587-2591.
  • Ramezani F, Maleki Z, Mortazavi H, Sabour S, Yadegari Z, Baharvand M. Salivary level of epidermal growth factor in recurrent aphthous stomatitis. Dent Med Prob. 2015; 52: 33-38.
  • Seifi S, Motallebnejad M, Maliji GH, Bijani A, Farnia S. Vascular endothelial growth factor in unstimulated saliva of the patients with minor aphtha. J Babol Univ Med Sci. 2012; 14: 64-69.
  • Konturek SJ, Brzozowski T, Konturek PK, Majka J, Dembiński A. Role of salivary glands and epidermal growth factor (EGF) in gastric secretion and mucosal integrity in rats exposed to stress. Regul Pept. 1991; 32: 203-215.
  • Gröschl M. The physiological role of hormones in saliva. Bioessays. 2009; 31: 843-852.
  • Marotta PS, FontesT, Armada L, Lima KC, Rocas IN, Siqueira JF. Type 2 diabetes mellitus and the prevalence of apical periodontitis. J Endod. 2012; 38: 297-300.
  • Nagy A, Nagashima H, Cha S, Oxford GE, Zelles T, Peck AB, et al. Reduced oral wound healing in the NOD mouse model for type 1 autoimmune diabetes and its reversal by epidermal growth factor supplementation. Diabetes. 2001; 50: 2100-2104.
  • Noguchi S, Ohba Y, Oka T. Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am J Physiol. 1991; 260: 620-625.
  • Cui RZ, Bruce AJ, Rogers RS. Recurrent aphthous stomatitis. Clin Dermatol. 2016; 34: 475-481.
  • Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 1990; 343: 82-85.
  • Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008; 16: 585-601.
آمار
تعداد مشاهده مقاله: 680
تعداد دریافت فایل اصل مقاله: 410


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب